Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA
Status:
Completed
Trial end date:
2021-02-04
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study to investigate the safety, tolerability, PK, and PD of ATI-450 plus
methotrexate versus methotrexate alone in patients with moderate to severe RA.